HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Individual and combined effects of N6-cyclopentyladenosine, flunarizine and diazepam on aminophylline-induced recurrent generalized seizures in mice.

Abstract
Protective effects of anticovulsant agents, N6-cyclopentyladenosine (CPA) and flunarizine (FLN) against aminophylline (AMPH) (280 mg/kg)-induced convulsions were tested in different groups of mice. All drugs were administered by intraperitoneal route. CPA (2 mg/kg and 4 mg/kg) delayed the time to onset of clonic convulsions (p < 0.05). The standard drug diazepam (DZP, 2.5 mg/kg) increased the time to onset of clonic and tonic convulsions to a statistically significant extent (p < 0.05 and p < 0.01, respectively). The AMPH-induced mortality (90.9%) was significantly reduced (p < 0.02) following the test anticonvulsants--CPA (2 mg/kg and 4 mg/kg), FLN (10 mg/kg) and the combination of CPA with FLN (though not to a significant extent), indicating partial involvement of adenosinergic and calcium related mechanisms, while DZP afforded maximum protection. However, none prevented the mortality in mice over 24 h. The results show the lethal effects of AMPH-induced seizures and involvement of multiple and complex neurotransmitter systems in this process which requires further investigation.
AuthorsJuliet Jaishree, Subramanyam Kumaresan, Suresh Sudha, Joy David, Chanda Kulkarni
JournalPolish journal of pharmacology (Pol J Pharmacol) 2003 Jul-Aug Vol. 55 Issue 4 Pg. 559-64 ISSN: 1230-6002 [Print] Poland
PMID14581714 (Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Anticonvulsants
  • Aminophylline
  • N(6)-cyclopentyladenosine
  • Adenosine
  • Diazepam
  • Flunarizine
Topics
  • Adenosine (administration & dosage, analogs & derivatives, therapeutic use)
  • Aminophylline
  • Animals
  • Anticonvulsants (administration & dosage, therapeutic use)
  • Diazepam (administration & dosage, therapeutic use)
  • Drug Therapy, Combination
  • Flunarizine (administration & dosage, therapeutic use)
  • Male
  • Mice
  • Recurrence
  • Seizures (chemically induced, mortality, prevention & control)
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: